Nick Vitanza, Pediatric Neuro-oncologist at Seattle Children’s Hospital, posted on X/Twitter:
“Honored to speak at SNO 2023 about our Seattle Children’s Therapeutics intracranial B7-H3 CART cell development and trials for patients with DIPG. Thank you Society for Neuro-Oncology, our wonderful clinical staff, my amazing lab, and our brave, wonderful patients. Photo courtesy Myron Evans.”
Source: Nick Vitanza/X